Lilly raises sales guidance for the third time this year as Zepbound sales soar
Strong Zepbound demand pushed Eli Lilly to lift its outlook again, and the stock closed at a record high.
Recap by typeshit. Full story at MarketWatch.
Strong Zepbound demand pushed Eli Lilly to lift its outlook again, and the stock closed at a record high.
Recap by typeshit. Full story at MarketWatch.
Novo reports nine-month results on Nov. 4, after a US judge declined its request to pause Lilly's weight-loss drug ads while the marketing dispute continues.
The Urban Zakapa singer shared gym-bound photos captioned with a call to go work out, as she focuses on exercise to hold her weight after stopping Wegovy.
The fitness creator argues people chase shortcuts and should handle walking, tracking food, water and 7 to 9 hours of sleep before adding peptides.
The Wegovy-sponsored CFL Division Finals kick off November 7 at 3:00 PM ET, the next step on the road to the Grey Cup.
A woman with four triglyceride-driven pancreatitis episodes came off insulin and had none for 12 months. The authors stress it shows association, not cause.
The once-daily tablet also brought about 4% placebo-adjusted weight loss in 13 weeks with no GI dropouts, per Ascletis. Obesity phase III data is expected in 2028.
Loading…